Editorial
doi: 10.1001/jama.2010.807.
Acting on comparative effectiveness research in COPD
- PMID: 20551414
- DOI: 10.1001/jama.2010.807
Item in Clipboard
Editorial
Acting on comparative effectiveness research in COPD
JAMA.
.
No abstract available
Comment in
-
Corticosteroid administration and treatment failure in acute exacerbation of chronic obstructive pulmonary disease.JAMA. 2010 Oct 13;304(14):1554; author reply 1554-6. doi: 10.1001/jama.2010.1438. JAMA. 2010. PMID: 20940378 No abstract available.
Comment on
-
Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease.JAMA. 2010 Jun 16;303(23):2359-67. doi: 10.1001/jama.2010.796. JAMA. 2010. PMID: 20551406
Similar articles
-
Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161409 Free PMC article.
-
Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2011 Dec 07;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. PMID: 21975759 Updated.
-
ICS and COPD: time to clear the air.Int J Chron Obstruct Pulmon Dis. 2009;4:289-90. doi: 10.2147/copd.s7143. Epub 2009 Aug 3. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 19684862 Free PMC article. No abstract available.
-
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD012066. doi: 10.1002/14651858.CD012066.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2023 Jun 5;6:CD012066. doi: 10.1002/14651858.CD012066.pub3. PMID: 28185242 Free PMC article. Updated.
-
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD006829. doi: 10.1002/14651858.CD006829.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972099 Free PMC article.
Cited by
-
Designing and evaluating a clustering system for organizing and integrating patient drug outcomes in personal health messages.AMIA Annu Symp Proc. 2012;2012:417-26. Epub 2012 Nov 3. AMIA Annu Symp Proc. 2012. PMID: 23304312 Free PMC article.
-
Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model.Evid Based Complement Alternat Med. 2019 Apr 17;2019:6478926. doi: 10.1155/2019/6478926. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31118965 Free PMC article.
-
The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.Chest. 2012 Jan;141(1):87-93. doi: 10.1378/chest.11-0024. Epub 2011 Jul 14. Chest. 2012. PMID: 21757568 Free PMC article.
-
Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial.Trials. 2014 May 1;15:153. doi: 10.1186/1745-6215-15-153. Trials. 2014. PMID: 24885672 Free PMC article. Clinical Trial.
-
Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and Pitfalls.Paediatr Drugs. 2018 Feb;20(1):1-7. doi: 10.1007/s40272-017-0256-y. Paediatr Drugs. 2018. PMID: 28776129 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
